IRWD compared with ARVN: revenue, margins and what each company keeps, and the suppliers and customers both name

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

ARVNArvinas, Inc.

Mkt capRevenueRevenue

Compare

IRWDIronwood Pharmaceuticals Inc

ARVNArvinas, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IRWD 8

ABBVAbbViesupplier

AZNAstraZeneca ABcustomer

—Ferringunlistedsupplier

—Courunlistedsupplier

4 more · IRWD chain ›

Shared 0

No shared counterparties.

Only ARVN 4

PFEPfizercustomer

NVSNovartis Pharmacustomer

—Yale Universityunlistedsupplier

—Bayer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

customer

IRWDIronwood Pharmaceuticals Inc

3.47▼−1.00%· post 3.47

Mkt cap$578.3MRevenue$113MQ2 FY26Revenue$296MFY25

ARVNArvinas, Inc.

7.53▼−4.20%· post 7.94

ClosedNov 2 '26

Mkt cap$491.7MRevenue$250MQ2 FY26Revenue$263MFY25

Compare

ClosedNov 2 '26

IRWDIronwood Pharmaceuticals Inc

ARVNArvinas, Inc.

3.47▼−1.00%post 3.47

Price

7.53▼−4.20%post 7.94

$578.3M

Mkt cap

$491.7M

Q2 FY26$113M

Revenue

$250MQ2 FY26

FY25$296M

Revenue

$263MFY25

IRWD3.47▼−1.00%vsARVN7.53▼−4.20%ClosedNov 2 '26